Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1

被引:0
|
作者
François Bertucci
Anthony Gonçalves
机构
[1] Institut Paoli-Calmettes,Department of Medical Oncology
[2] Department of Molecular Oncology,Faculty of Medicine
[3] Centre de Recherche en Cancérologie de Marseille (CRCM),undefined
[4] CNRS U7258,undefined
[5] INSERM U1068,undefined
[6] Aix-Marseille University,undefined
来源
Current Oncology Reports | 2017年 / 19卷
关键词
Breast cancer; Expression; Immune response; Monoclonal antibodies; PD-1; PD-L1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1
    Villanueva, Nicolas
    Bazhenova, Lyudmila
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2018, 12
  • [32] PD-1 and PD-L1 Expression in Indian Women with Breast Cancer
    Bharadwa, Kishan R.
    Dasgupta, Kuheli
    Narayana, Suma Mysore
    Ramachandra, C.
    Babu, Suresh M. C.
    Rangarajan, Annapoorni
    Kumar, Rekha, V
    EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (01) : 21 - 29
  • [33] Small Molecules as PD-1/PD-L1 Pathway Modulators for Cancer Immunotherapy
    Jiao, Peifu
    Geng, Qiaohong
    Jin, Peng
    Su, Gaoxing
    Teng, Houyun
    Dong, Jinlong
    Yan, Bing
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (41) : 4911 - 4920
  • [34] Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases
    Singh, Vishakha
    Khurana, Amit
    Allawadhi, Prince
    Banothu, Anil Kumar
    Bharani, Kala Kumar
    Weiskirchen, Ralf
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [35] PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
    Liu, Jinhua
    Chen, Zichao
    Li, Yaqun
    Zhao, Wenjie
    Wu, JiBiao
    Zhang, Zhen
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [36] PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression
    Alkaabi, Duaa
    Arafat, Kholoud
    Sulaiman, Shahrazad
    Al-Azawi, Aya Mudhafar
    Attoub, Samir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [37] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [38] PD-1 and PD-L1 Expression in Male Breast Cancer in Comparison with Female Breast Cancer
    Manson, Quirine F.
    ter Hoeve, Natalie D.
    Buerger, Horst
    Moelans, Cathy B.
    van Diest, Paul J.
    TARGETED ONCOLOGY, 2018, 13 (06) : 769 - 777
  • [39] PD-1 and PD-L1 Expression in Male Breast Cancer in Comparison with Female Breast Cancer
    Quirine F. Manson
    Natalie D. ter Hoeve
    Horst Buerger
    Cathy B. Moelans
    Paul J. van Diest
    Targeted Oncology, 2018, 13 : 769 - 777
  • [40] PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
    Bocanegra, Ana
    Blanco, Ester
    Fernandez-Hinojal, Gonzalo
    Arasanz, Hugo
    Chocarro, Luisa
    Zuazo, Miren
    Morente, Pilar
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 17